{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T01:12:13Z","timestamp":1725671533663},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1994,5,1]],"date-time":"1994-05-01T00:00:00Z","timestamp":767750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[1994,5]]},"DOI":"10.1007\/bf00593260","type":"journal-article","created":{"date-parts":[[2004,11,24]],"date-time":"2004-11-24T05:00:48Z","timestamp":1101272448000},"page":"281-284","source":"Crossref","is-referenced-by-count":5,"title":["Single photon emission computed tomography with123I-IMP in three cases of the neuroleptic malignant syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"K.","family":"Nisijima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"248","volume-title":"Handbook of clinical neurology: diseases of the basal ganglia","author":"J Delay","year":"1968","unstructured":"Delay J, Deniker P (1968) Drug-induced extrapyramidal syndromes. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology: diseases of the basal ganglia. Elsevier-North Holland, New York, pp 248?266"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","volume":"142","author":"JL Levenson","year":"1985","unstructured":"Levenson JL (1985) Neuroleptic malignant syndrome. Am J Psychiatry 142: 1137?1145","journal-title":"Am J Psychiatry"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","volume":"22","author":"G Addonizio","year":"1987","unstructured":"Addonizio G, Susman VL, Roth SD (1987) Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry 22: 1004?1020","journal-title":"Biol Psychiatry"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1989.00390090009002","volume":"149","author":"MR Rosenberg","year":"1989","unstructured":"Rosenberg MR, Green M (1989) Neuroleptic malignant syndrome: review of response to therapy. Arch Intern Med 149: 1927?1931","journal-title":"Arch Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410140117","volume":"14","author":"JE Granato","year":"1983","unstructured":"Granato JE, Stern BJ, Ringel A, Karim AH, Krumholz A, Coyle J, Adler S (1983) Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine. Ann Neurol 14: 89?90","journal-title":"Ann Neurol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","volume":"31","author":"VW Henderson","year":"1981","unstructured":"Henderson VW, Wooten GF (1981) Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade? Neurology 31: 132?137","journal-title":"Neurology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00005053-198105000-00011","volume":"169","author":"M Toru","year":"1981","unstructured":"Toru M, Matsuda O, Makiguchi K, Sugano K (1981) Neuroleptic malignant syndrome-like state following withdrawal of antiparkinsonian drugs. J Nerv Ment Dis 169: 324?327","journal-title":"J Nerv Ment Dis"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1109\/TNS.1978.4329385","volume":"25","author":"LT Chang","year":"1978","unstructured":"Chang LT (1978) A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 25: 638?643","journal-title":"IEEE Trans Nucl Sci"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000116625","volume":"31","author":"J Reuck De","year":"1991","unstructured":"De Reuck J, Van Aken J, Van Landegem W, Colardyn F (1991) Positron emission tomographic studies of changes in cerebral blood flow and oxygen metabolism in neuroleptic malignant syndrome. Eur Neurol 31: 1?6","journal-title":"Eur Neurol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/jcbfm.1982.26","volume":"2","author":"A G\u00fcell","year":"1982","unstructured":"G\u00fcell A, G\u00e9raud G, Jauzac Ph, Victor G, Arn\u00e9-B\u00e8s MC (1982) Effects of a dopaminergic agonist (Piribedil) on cerebral blood flow in man. J Cereb Blood Flow Metabol 2: 255?257","journal-title":"J Cereb Blood Flow Metabol"},{"key":"CR11","first-page":"947","volume":"21","author":"HS Winchell","year":"1980","unstructured":"Winchell HS, Horst WD, Braun L, Oldendorf WH, Hattner R, Parker H (1980) N-isopropyl-(123I)p-iodoamphetamine: singlepass brain uptake and washout; binding to brain synaptosomes and localization in dogs and monkey brain. J Nucl Med 21: 947?952","journal-title":"J Nucl Med"},{"key":"CR12","first-page":"196","volume":"23","author":"DE Kuhl","year":"1982","unstructured":"Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, Wu JL, Lin TH, Phelps ME (1982) Quantifying local cerebral blood flow by N-isopropyl-p-(123I)iodoamphetamine (IMP) tomography. J Nucl Med 23: 196?203","journal-title":"J Nucl Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00395613","volume":"30","author":"T Ueda","year":"1988","unstructured":"Ueda T, Kinoshita K, Watanabe K, Hoshi H, Jinnouchi S (1988) Early and delayed single photon emission CT in various cerebral diseases using N-isopropyl-p-(123I)iodoamphetamine. Neuroradiology 30: 123?131","journal-title":"Neuroradiology"},{"key":"CR14","first-page":"178","volume":"27","author":"H Creutzig","year":"1986","unstructured":"Creutzig H, Schober O, Gielow P, Friedrich R, Becker H, Dietz H, Hundeshagen H (1986) Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine. J Nucl Med 27: 178?183","journal-title":"J Nucl Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/BF00631769","volume":"15","author":"M Tsukada","year":"1989","unstructured":"Tsukada M, Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Miyake Y, Mizuguchi M, Gunasekera R, Masuda K (1989) Evaluation of the significance of ?redistribution? in I-123 IMP SPECT in cerebrovascular disorders ? a comparative study with PET. Eur J Nucl Med 15: 746?749","journal-title":"Eur J Nucl Med"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00593260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00593260\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00593260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T19:51:04Z","timestamp":1705348264000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00593260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,5]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994,5]]}},"alternative-id":["BF00593260"],"URL":"https:\/\/doi.org\/10.1007\/bf00593260","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,5]]}}}